Thymoquinone protects cultured rat primary neurons against amyloid β-induced neurotoxicity

Biochemical and Biophysical Research Communications

Volumn 433, Issue 4, 2013, Pages 362-367

  Alhebshi, A H ^a   Gotoh, M ^a   Suzuki, I ^a  

^a TOKYO UNIVERSITY OF TECHNOLOGY   (Japan)

Author keywords

Alzheimer disease; Amyloid beta; Cultured primary neurons; FM1 43; Multielectrode array; Thymoquinone

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; REACTIVE OXYGEN METABOLITE; THYMOQUINONE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; EMBRYO; IN VITRO STUDY; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; RAT;

AMYLOID BETA-PEPTIDES; ANIMALS; BENZOQUINONES; CELL SURVIVAL; CELLS, CULTURED; CYTOPROTECTION; FLUORESCENCE; HIPPOCAMPUS; MEMBRANE POTENTIAL, MITOCHONDRIAL; NEURONS; NEUROPROTECTIVE AGENTS; NIGELLA SATIVA; PEPTIDE FRAGMENTS; PRIMARY CELL CULTURE; PYRIDINIUM COMPOUNDS; QUATERNARY AMMONIUM COMPOUNDS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; RHODAMINE 123; SEEDS; SYNAPTIC TRANSMISSION; SYNAPTIC VESICLES; TIME FACTORS;

NIGELLA SATIVA; RATTUS;

EID: 84876476066     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.11.139     Document Type: Article

References (32)

1. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 2001, 81:741-766.
2. Selkoe D.J. Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloidβ-protein. J. Alzheimers Dis. 2001, 3:75-80.
3. Cole S.L., Vassar R. The role of amyloid precursor protein processing by BACE1, the β-secretase, in Alzheimer disease pathophysiology. J. Biol. Chem. 2008, 283:29621-29625.
4. Mann D.M., Iwatsubo T., Cairns N.J., et al. Amyloid β protein (Aβ) deposition in chromosome 14-linked Alzheimer's disease: predominance of Aβ42. Ann. Neurol. 1996, 40:149-156.
5. Abramov A.Y., Canevari L., Duchen M.R. Beta amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH Oxidase. J. Neurosci. 2004, 24:565-575.
6. Selkoe D.J. Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior. Behav. Brain Res. 2008, 192:106-113.
7. Akiyama H., Barger S., Barnum S., et al. Inflammations and Alzheimer disease. Neurobiol Aging 2000, 21:383-421.
8. Palop J.J., Mucke L. Amyloid-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks. Nat. Neurosci. 2010, 13:812-818.
9. Sotthibundhu A., Sykes A.M., Fox B., et al. (1-42) induces neuronal death through the p75 neurotrophin receptor. J. Neurosci. 2008, 28:3941-3946.
10. Yang F., Lim G.P., Begum A.N., et al. Curcumin inhibits formation of amyloid β oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J. Biol. Chem. 2005, 280:5892-5901.
11. Sharma N.K., Ahirwar D., Jhade D., Gupta S. Medicinal and pharmacological potential of nigella sativa: a review. J. Ethnopharmacol. 2009, 13:946-955.
12. Ali B.H., Blunden G. Pharmacological and toxicological properties of Nigella sativa. Phytother Res. 2003, 17:299-305.
13. El Tahir K.E., Ashour M.M., Al-Harbi M.M. The respiratory effects of the volatile oil of the black seed (Nigella sativa) in guinea-pigs: elucidation of the mechanism(s) of action. Gen. Pharmacol. 1993, 24:1115-1122.
14. Chehl N., Chipitsyna G., Gong Q., et al. Anti-inflammatory effects of the Nigella sativa seed extract, thymoquinone, in pancreatic cancer cells. HPB (Oxford) 2009, 11:373-381.
15. Radad K., Moldzio R., Taha M., Rausch W.D. Thymoquinone protects dopaminergic neurons against MPP+ and rotenone. Phytother. Res. 2009, 23:696-700.
16. Hamdy N.M., Taha R.A. Effects of Nigella sativa oil and thymoquinone on oxidative stress and neuropathy in streptozotocin-induced diabetic rats. Pharmacology 2009, 84:127-134.
17. Kanter M. Nigella sativa and derived thymoquinone prevents hippocampal neurodegeneration after chronic toluene exposure in rats. Neurochem. Res. 2008, 33:579-588.
18. Gilhotra N., Dhingra D. Thymoquinone produced antianxiety-like effects in mice through modulation of GABA and NO levels. Pharmacol. Rep. 2011, 63:660-669.
19. Mohamed A., Afridi D.M., Garani O., Tucci M. Thymoquinone inhibits the activation of NF-kappa B in the brain and spinal cord of experimental autoimmune encephalomyelitis. Biomed. Sci. Instrum. 2005, 41:388-393.
20. Arendt T. Synaptic degeneration in Alzheimer's disease. Acta Neuropathol. 2009, 118:167-179.
21. Varghese K., Molnar P., Das M., et al. A new target for amyloid beta toxicity validated by standard and high-throughput electrophysiology. PLoS One 2010, 5:8643-8651.
22. Fath T., Ke Y.D., Gunning P., et al. Primary support cultures of hippocampal and substantia nigra neurons. Nat. Protoc. 2009, 4:78-85.
23. Cousin M.A., Robinson P.J. Mechanisms of synaptic vesicle recycling illuminated by fluorescent dyes. J. Neurochem. 1999, 73:2227-2239.
24. Suzuki I., Yasuda K. Detection of tetanus-induced effects in linearly lined-up micropatterned neuronal networks: application of a multi-electrode array chip combined with agarose microstructures. Biochem. Biophys. Res. Commun. 2007, 356:470-475.
25. Suzuki I., Sugio Y., Jimbo Y., Yasuda K. Stepwise pattern modification of neuronal network in photo-thermally-etched agarose architecture on multi-electrode array chip for individual-cell-based electrophysiological measurement. Lab Chip. 2005, 5:241-247.
26. Santos M.J., Quintanilla R.A., Toro A., et al. Peroxisomal proliferation protects from beta-amyloid neurodegeneration. J. Biol. Chem. 2005, 280:41057-41068.
27. Orbán G., Völgyi K., Juhász G., et al. Different electrophysiological actions of 24- and 72-hour aggregated amyloid-beta oligomers on hippocampal field population spike in both anesthetized and awake rats. Brain Res. 2010, 1354:227-235.
28. Al-Majed A.A., Al-Omar F.A., Nagi M.N. Neuroprotective effects of thymoquinone against transient forebrain ischemia in the rat hippocampus. Eur. J. Pharmacol. 2006, 543:40-47.
29. Prasad K.N., Cole W.C., Prasad K.C. Risk factors for Alzheimer's disease: role of multiple antioxidants, non-steroidal anti-inflammatory and cholinergic agents alone or in combination in prevention and treatment. J. Am. Coll. Nutr. 2002, 21:506-522.
30. Qu M., Li L., Chen C., et al. Protective effects of lycopene against amyloid β-induced neurotoxicity in cultured rat cortical neurons. Neurosci. Lett. 2011, 505:286-290.
31. Parodi J., Sepúlveda F.J., Roa J., et al. Beta-amyloid causes depletion of synaptic vesicles leading to neurotransmission failure. J. Biol. Chem. 2010, 285:2506-2514.
32. Skovronsky D.M., Doms R.W., Lee V.M.-Y. Detection of a novel intraneuronal pool of insoluble amyloid β protein that accumulates with time in culture. J. Cell. Biol. 1998, 141:1031-1039.